MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41591-025-03956-5

Медицинская библиотека · Nature medicine · 2025

A consensus immune dysregulation framework for sepsis and critical illnesses.

Moore Andrew R, Zheng Hong, Ganesan Ananthakrishnan, Hasin-Brumshtein Yehudit, Maddali Manoj V, Levitt Joseph E, van der Poll Tom, Lu Jingyi, Bouma Hjalmar R, Scicluna Brendon P, Giamarellos-Bourboulis Evangelos J, Kotsaki Antigone, Martin-Loeches Ignacio, Garduno Alexis, Hinson Jeremiah, Rothman Richard E, Sevransky Jonathan, Wright David W, Atreya Mihir R, Moldawer Lyle L, Efron Philip A, Kralovcova Marcela, Karvunidis Thomas, Giannini Heather M, Meyer Nuala J, Sweeney Timothy E, Rogers Angela J, Khatri Purvesh

СтатьяКлинические рекомендацииПеревод в очереди

Аннотация

Critical care syndromes such as sepsis, acute respiratory distress syndrome (ARDS) and trauma continue to have unacceptably high morbidity and mortality, with progress limited by the inherent heterogeneity within syndromic illnesses. Although numerous immune endotypes have been proposed for sepsis and critical care, the similarities and differences between these endotypes remain unclear, hindering clinical translation. The SUBSPACE consortium is an international consortium that aims to advance precision medicine in critical care through the sharing of transcriptomic data. Here, evaluating the overlap of existing immune endotypes in sepsis across >7,074 samples from 37 independent cohorts, we developed cell-type-specific gene expression signatures to quantify dysregulation within immune compartments. Myeloid and lymphoid dysregulation were associated with disease severity and mortality across all cohorts. Importantly, this dysregulation was also observed in patients with ARDS, trauma and burns, suggesting a conserved mechanism across various critical illness syndromes. Moreover, analysis of randomized controlled trial data revealed that myeloid and lymphoid dysregulation are associated with differential mortality in patients treated with anakinra in the SAVE-MORE trial (n = 452) and corticosteroids in the VICTAS (n = 89) and VANISH (n = 117) trials, underscoring their prognostic and therapeutic implications. In conclusion, our proposed immunology-based framework for quantifying cellular compartment dysregulation offers a potentially valuable tool for understanding immune dysregulation in critical illness with prognostic and therapeutic significance.

Для цитирования: Moore Andrew R, Zheng Hong, Ganesan Ananthakrishnan, Hasin-Brumshtein Yehudit, Maddali Manoj V, Levitt Joseph E, van der Poll Tom, Lu Jingyi, Bouma Hjalmar R, Scicluna Brendon P, Giamarellos-Bourboulis Evangelos J, Kotsaki Antigone, Martin-Loeches Ignacio, Garduno Alexis, Hinson Jeremiah, Rothman Richard E, Sevransky Jonathan, Wright David W, Atreya Mihir R, Moldawer Lyle L, Efron Philip A, Kralovcova Marcela, Karvunidis Thomas, Giannini Heather M, Meyer Nuala J, Sweeney Timothy E, Rogers Angela J, Khatri Purvesh. A consensus immune dysregulation framework for sepsis and critical illnesses.. Nature medicine. 2025. DOI: 10.1038/s41591-025-03956-5.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.